(UPDATE) Niraparib
Bevacizumab
Mirvetuximab Soravtasine-gynx (Elahere)
Olaparib
Rivkin Center for Ovarian Cancer
Foundation for Women's Cancer
American Cancer Society
NCCN COVID-19 Resources Page